✦ LIBER ✦

Cross-intolerance to imatinib, dasatinib and nilotinib therapy in a patient with chronic myeloid leukaemia

✍ Scribed by Igor Novitzky-Basso; Charles Craddock

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dasatinib is safe and effective in unsel

✍ Roberto Latagliata; Massimo Breccia; Fausto Castagnetti; Fabio Stagno; Luigiana 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 382 KB

PCN13 Cost-Effectiveness Analysis of Nil

✍ Niu, X.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

A retrospective analysis of therapy adhe

✍ Guérin, Annie; Chen, Lei; Wu, Eric Q.; Ponce de Leon, Diego; Griffin, James D. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 174 KB

PCN99 Cost-Effectiveness of Dasatinib ve

✍ Darba, J.; Kaskens, L.; Abecasis, M.; Vitorino, R.; Carrasco, J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Adherence to treatment with second-line

✍ Yood, Marianne Ulcickas; Oliveria, Susan A.; Cziraky, Mark; Hirji, Ishan; Hamdan 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 206 KB

Comparing nilotinib with dasatinib as se

✍ Griffin, James D.; Guerin, Annie; Chen, Lei; Macalalad, Alexander R.; Luo, Jiayu 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 305 KB